Endothelial markers in diabetes mellitus

被引:28
作者
Galajda, P
Martinka, E
Mokan, M
Kubisz, P
机构
[1] FAC HOSP,DEPT INTERNAL MED 1,MARTIN 03659,SLOVAKIA
[2] FAC HOSP,DEPT HEMATOL & TRANSFUSIOL,MARTIN 03659,SLOVAKIA
关键词
von Willebrand factor; thrombomodulin; tissue factor pathway inhibitor; diabetes mellitus;
D O I
10.1016/S0049-3848(96)00222-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we examined 22 NIDDM patients without vascular complications and 17 age-matched healthy blood donors. Von Willebrand factor (vWF) levels were significantly increased in NIDDM patients compared to healthy blood donors (1.33+/-0.39 vs 1.01+/-0.27 IU/ml p=0.006), while thrombomodulin (TM) levels were similar in the both groups. vWF levels correlated with calcium dependent secretion parameters such as C-peptide (r=0.680, p<0.001) and PF4 (r=0.613, p <0.01) and did not correlate with calcium-independent markers of endothelial injury such as TM (r=0.287, p=0.196) and TFPI (r=0.296, p=0.181). Therefore it seems that increased levels of Ca-i-dependent endothelial and platelet activation markers may precede the signs of endothelial damage. This hypothesis requires further research. Copyright (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:63 / 65
页数:3
相关论文
共 8 条
[1]   A RELIABLE MARKER OF ENDOTHELIAL-CELL DYSFUNCTION - DOES IT EXIST [J].
BLANN, AD ;
TABERNER, DA .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) :244-248
[2]   FREE-RADICAL ACTIVITY AND HEMOSTATIC FACTORS IN NIDDM PATIENTS WITH AND WITHOUT MICROALBUMINURIA [J].
COLLIER, A ;
RUMLEY, A ;
RUMLEY, AG ;
PATERSON, JR ;
LEACH, JP ;
LOWE, GDO ;
SMALL, M .
DIABETES, 1992, 41 (08) :909-913
[3]   ELEVATION OF PLASMA THROMBOMODULIN LEVEL IN DIABETIC-PATIENTS WITH EARLY DIABETIC NEPHROPATHY [J].
IWASHIMA, Y ;
SATO, T ;
WATANABE, K ;
OOSHIMA, E ;
HIRAISHI, S ;
ISHII, H ;
KAZAMA, M ;
MAKINO, I .
DIABETES, 1990, 39 (08) :983-988
[4]   TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY IN PATIENTS WITH IDDM [J].
LEURS, PB ;
VANOERLE, R ;
HAMULYAK, K ;
WOLFFENBUTTEL, BHR .
DIABETES, 1995, 44 (01) :80-84
[5]   DIABETES-MELLITUS - A DISEASE OF ABNORMAL CELLULAR CALCIUM-METABOLISM [J].
LEVY, J ;
GAVIN, JR ;
SOWERS, JR .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (03) :260-273
[6]  
SEIGNEUR M, 1993, INT ANGIOL, V12, P85
[7]  
YAMAGUCHI T, 1991, DIABETES RES CLIN EX, V18, P89
[8]   Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy [J].
Yokoyama, H ;
Myrup, B ;
Rossing, P ;
Ostergaard, PB .
DIABETES CARE, 1996, 19 (05) :441-445